SEC Form D private-offering filing
BIOVENTRIX, INC.
A new SEC Form D private-offering notice from Mansfield, MA, a $6,000,000 filer-stated offering target in Biotech. The source filing is one click away.
Medical device company developing minimally invasive, catheter based treatments for congestive heart failure, including the Revivent System for ischemic cardiomyopathy
Filed 2026-04-24Filed to raise $6,000,000First money in 2026-04-16Raised so far $705,000HQ (as filed) Mansfield, MASector Biotech ✓Stage (inferred) EarlyCall status Call-ready
Source linked the Form D on EDGAR↗Website verified bioventrix.com↗Named in the filing 4 executives & directors
This is a public SEC Form D private-offering notice, the filer's own statement to the SEC. Amounts are offering targets, not confirmed closes. Takeoff Radar pulls Form D nightly from EDGAR and links every filing to its source.